nVent Electric plc Ordinary Shares NVT 深 沪
等待开盘 08-15 09:30:00 美东时间
89.80
-0.810
-0.89%
华盛通- 最 高90.64
- 今 开90.01
- 成交量 142.94万股
- 最 低 89.09
- 昨 收 90.61
- 总市值 148.17亿
- 52周最高 92.75
- 市盈率 静 45.52
- 换手率 0.87%
- 52周最低 41.305
- 委 比 0.00%
- 总股本 1.65亿
- 历史最高 92.75
- 量 比 0.70
- 振 幅 1.71%
- 历史最低 6.55
- 每 手 1
- 风险率 8.93%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅123.33%！Maxim Group上调优利系统目标价至9美元，评级升至"买入"
今日重点评级关注：Maxim Group：上调优利系统评级至"买入"，目标价9美元；Canaccord Genuity：维持Enovix"买入"评级，目标价从20美元升至22美元
08-05 08:35
Monolithic Power Systems, Workiva, Interface, AppFolio And Other Big Stocks Moving Higher On Friday
U.S. stocks were lower, with the Dow Jones index falling around 500 points on F...
08-01 22:44
nVent Electric Sees Q3 Adj EPS $0.86-$0.88 vs $0.84 Est, Company Estimates Q3 Reported Sales Growth Of 27%-29% And Organic Sales Growth Of 11%-13%
nVent Electric (NYSE:NVT) is looking for Q3 Adj EPS of $0.86-$0.88 vs $0.84 analyst estimate..
08-01 18:47
nVent Electric Q2 Adj. EPS $0.86 Beats $0.79 Estimate, Sales $963.000M Beat $897.872M Estimate
nVent Electric (NYSE:NVT) reported quarterly earnings of $0.86 per share which beat the analyst consensus estimate of $0.79 by 9.55 percent. This is a 4.88 percent increase over earnings of $0.82 per share from the same
08-01 18:44
Earnings Scheduled For August 1, 2025
Companies Reporting Before The Bell • Brookfield Business (NYSE:BBUC) is expect...
08-01 16:32
What to Expect from nVent Electric's Earnings
nVent Electric (NYSE:NVT) is set to give its latest quarterly earnings report o...
07-31 23:02
美股大行评级 | 瑞银上调微软(MSFT)目标价升至600美元；花旗维持Unity 买入"评级，目标价从29美元升至44美元
今日重点评级关注：瑞银：维持泰尼特"买入"评级，目标价从230美元升至238美元；杰富瑞：维持BellRing Brands"买入"评级，目标价从80美元升至82美元
07-24 09:49
Roth Capital Initiates Coverage On nVent Electric with Buy Rating, Announces Price Target of $89
Roth Capital analyst Justin Clare initiates coverage on nVent Electric (NYSE:NVT) with a Buy rating and announces Price Target of $89.
07-24 01:55
蓝帆医疗上半年预亏超1亿元，重金投入下心脑血管业务有望扭亏
本文来源：时代商业研究院 作者：雷小艳 来源|时代商业研究院 作者|雷小艳 7月15日，蓝帆医疗（002382.SZ）发布半年度业绩预告。该预告显示...
07-22 23:52
美股大行评级 | 潜在涨幅94.06%！摩根大通上调BioMarin制药目标价至113美元，维持"超配"评级
今日重点评级关注：摩根大通：维持BioMarin Pharmaceutical"超配"评级，目标价从108美元升至113美元；Oppenheimer：维持P10"跑赢大市"评级，目标价从20美元升至21美元
07-15 09:23
